Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.
about
Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas.Galectins and gliomas.Immunohistochemistry as an important tool in biomarkers detection and clinical practice.Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children.Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behaviorGalectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survivalSPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsGalectin-1 and immunotherapy for brain cancer.Galectins as cancer biomarkers.Systematic review of protein biomarkers of invasive behavior in glioblastoma.Galectins and neovascularization in central nervous system tumors.Galectins in tumor angiogenesisGalectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.Considering temozolomide as a novel potential treatment for esophageal cancer.Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma.Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration.Galectin-3 in preneoplastic lesions of glioma.Glycosylation Changes in Brain Cancer.S100A5: a marker of recurrence in WHO grade I meningiomas.Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.The Role of Galectins in Cervical Cancer Biology and Progression.Combined temozolomide and ionizing radiation induces galectin-1 and galectin-3 expression in a model of human glioma
P2860
Q32001534-FDBA93C2-5688-412E-AFFA-EAAFC8615316Q33588438-8419F3F0-D314-4F27-B538-9B969B4CB5C0Q33704442-9D8C08AB-55F4-495A-8BE3-B53EC700E4F7Q34131307-1505B396-2477-4CFD-B2BE-288B4BCD2430Q35228388-72871520-2BE8-41D5-AA6D-2DA28E5F8D3AQ35392528-0B0E864C-297D-4273-A845-A04B00146A11Q35995952-AEE34E1A-244F-48BE-83E4-8D4FB65DDEA7Q36184329-F2FC3890-8436-4037-9457-90E50623838BQ37862237-BEBE22F7-C7B1-485F-8F55-8408C14B1DBAQ38105320-57DE61A2-2A23-4BED-81C5-661613D099E1Q38165795-C1D37DEA-024F-41A0-8C22-C5A4C3DFB49DQ38214808-FD6B7794-DB7C-4BF9-9D2C-AC1D66F4C2DFQ38269050-B269AA16-E143-424C-8E4B-E807366CF319Q38755698-9FE9FD17-F74B-498A-9368-3024470E2028Q39555301-2949CC5F-3A67-42AF-BF53-6669438D3038Q39986427-13B9B2AA-6E17-4F7E-900E-E646883DF6ADQ43890804-BB772D90-A488-49BD-99AF-AAD3C86CA322Q46639546-0FF3667D-9549-4896-A804-2FBBA0B0BB4BQ47691736-983BEAE2-F568-47B8-9525-799DE0846BE6Q47885335-FEBC4E71-BFC1-407F-8CC8-423472EB9E40Q48958266-5AB18D67-09B2-495B-897D-9E11795A034CQ55152503-DB4C7C36-12D0-4486-BCD2-361827AB6806Q57462651-53C77A93-CF72-41AF-9B6F-028D14EAE732
P2860
Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@en
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@nl
type
label
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@en
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@nl
prefLabel
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@en
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@nl
P2093
P2860
P1476
Galectin-3 and galectin-3-bind ...... ours and related angiogenesis.
@en
P2093
Burchert M
Decaestecker C
Gordower L
P2860
P304
P356
10.1046/J.1365-2990.1999.00192.X
P577
1999-08-01T00:00:00Z